Evidence map›Paper›PMID 28331788›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2017

Periodic Mesoporous Organosilica Coated Prussian Blue for MR/PA Dual-Modal Imaging-Guided Photothermal-Chemotherapy of Triple Negative Breast Cancer.

Wei Tian, Yunyan Su, Ying Tian, Shouju Wang, Xiaodan Su, Ying Liu, Yunlei Zhang, Yuxia Tang, Qianqian Ni, Wenfei Liu and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 77 citations in OpenAlex.

  1. Programmable Organic APharmaceutics · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Wei TianDepartment of Medical Imaging Jinling Hospital Nanjing Clinical School Southern Medical University (Guangzhou) Nanjing 210002 Jiangsu P. R. China; Department of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Yunyan SuDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Ying TianDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Shouju WangDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Xiaodan SuKey Laboratory for Organic Electronics & Information Displays and Institute of Advanced Materials Nanjing University of Posts and Telecommunications Nanjing 210046 Jiangsu P. R. China.
Ying LiuDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Yunlei ZhangDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Yuxia TangDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Qianqian NiDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Wenfei LiuDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Meng DangDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Chunyan WangDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Junjie ZhangDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China.
Zhaogang TengDepartment of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China; State Key Laboratory of Analytical Chemistry for Life Science School of Chemistry and Chemical Engineering Nanjing University Nanjing 210093 Jiangsu P. R. China.
Guangming LuDepartment of Medical Imaging Jinling Hospital Nanjing Clinical School Southern Medical University (Guangzhou) Nanjing 210002 Jiangsu P. R. China; Department of Medical Imaging Jinling Hospital School of Medicine Nanjing University Nanjing 210002 Jiangsu P. R. China; State Key Laboratory of Analytical Chemistry for Life Science School of Chemistry and Chemical Engineering Nanjing University Nanjing 210093 Jiangsu P. R. China.
Nanjing General Hospital of Nanjing Military Command · CNNanjing Medical University · CNNanjing University · CNNanjing University of Posts and Telecommunications · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complete eradication of highly aggressive triple negative breast cancer (TNBC) remains a notable challenge today. In this work, an imaging-guided photothermal-chemotherapy strategy for TNBC is developed for the first time based on a periodic mesoporous organosilica (PMO) coated Prussian blue (PB@PMO) nanoplatform. The PB@PMOs have organic-inorganic hybrid frameworks, uniform diameter (125 nm), high surface area (866 m

Indexed as

imaging‐guided therapynanoplatformperiodic mesoporous organosilicaPrussian bluetriple negative breast cancer

Identifiers

PMID28331788
PMCPMC5357980
OpenAlexW2552126623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.